RNAases (ribonucleases), purified from four human tissues, as well as bovine pancreatic RNAase (RNAase A), were studied by immunodiffusion methods and by two different primary binding tests. The enzymes fell into two groups immunologically, those purified from plasma and pancreas in one and those from spleen and liver in the other. No antigenic cross-reaction between the two groups was detected by any of the immunoassays used. There was a slight antigenic cross-reaction between the human and bovine pancreatic RNAases. The liver and spleen RNAases were immunologically identical by all criteria used, whereas a small but consistent antigenic difference between the human plasma and human pancreas enzymes was detected. The significance of this difference between the human plasma and pancreas RNAases is discussed in relation to similarities and differences in their properties.
Reports of patients with cystic fibrosis (Bardon et al., 1976) and ofpatients with pancreatic carcinoma (Reddi & Holland, 1976) suggest that RNAaset activity in plasma may be a useful marker of certain disease states involving the pancreas. However, since there are two primary types of soluble human RNAases, the identification of the enzyme(s) responsible for abnormal RNAase activity in such pathological states remains to be determined. One major type of soluble human RNAase has been purified from plasma and tends to hydrolyse at cytidylic acid residues when reacting with yeast RNA (Schmukler et al., 1975) . The other major type of soluble human RNAase preferentially releases purine residues at the 5'-terminus of the phosphodiester bond and has been purified from human spleen (Neuwelt et al., 1976) and from human liver . Although these two types of RNAases have different specificities, it is not always possible to identify unambiguously the presence of one and/or both of these enzymes in crude preparations, such as plasma, on the basis of hydrolysis of synthetic substrates. As a result, in the present work we attempted to compare and contrast the antigenicity of these two types of human RNAases in the hope of obtaining a more unambiguous means of differentiating between them.
The enzymes studied were RNAases purified from human spleen (Neuwelt et al., 1976) , human liver and human plasma (Schmukler et al., 1975) , as well as commercially purified RNAase A (bovine pancreas). Because of the recent interest in plasma RNAase activity in patients with pancreatic disorders, an additional RNAase, purified 916-fold from human pancreas, was also studied. Although preliminary immunological investigations were carried out by classical immunodiffusion techniques, these techniques can lack the necessary sensitivity for antigenic comparisons of enzymes (Neuwelt et al., 1973) . As a result, more sensitive and specific immunoassays which directly measure the interaction between antigen and antibody (i.e. primary binding tests) were also utilized. The primary binding tests chosen for the present studies, the blocking primary enzyme immunoassay and the (NH4)2SO4 test, were specially designed so as not to require either purified antigen or monospecific antibody (Neuwelt et al., 1973) .
Experimental

Materials
Samples of human spleen, pancreas and liver were obtained from autopsy specimens kindly provided by the Baltimore City Medical Examiner's office. Human plasma was obtained from normal volunteers. RNAase A (chromatographically homogeneous) was obtained from Sigma Chemical Co., St. Louis, MO, U.S.A.
The methods used in the purification of yeast RNA and ribonucleotide polymers, as well as their com-mercial sources, have been described elsewhere (Schmukler et al., 1975) .
The polyamine spermidine was obtained from Calbiochem, San Diego, CA, U.S.A.
CNBr-activated Sepharose 4B was purchased from Pharmacia, Piscataway, NJ, U.S.A.
The commercial sources and the molecular weights of the individual proteins used as standards in the estimation of the molecular weight of the human pancreatic ribonuclease were the same as those used in the determination of the human plasma RNAase as reported previously (Schmukler et al., 1975) .
Complete Freund's adjuvant was purchased from Difco Laboratories, Detroit, MI, U.S.A.
Assay ofhuman ribonucleases
The standard assay system for the plasma and pancreas RNAases contained 1.5,umol of poly(C), lOOumol of Tris/HCl buffer, pH7.5, 0.5mg of bovine serum albumin and enzyme in 1 ml. After incubation for 15min at 25°C, the reaction was stopped by the addition of 1 ml of 2M-HClO4, and the vessel containing the reaction mixture was placed in an ice bath for 10min. The cloudy solution was then clarified by centrifugation (300OOg for 10min) and the A260 of the acid-soluble nucleotides measured (Kalnitsky et al., 1959 ). An enzyme unit is defined as the amount of enzyme needed to cause an increase in A260 of 1.0 under the conditions of the assay.
The standard assay system for the liver and spleen RNAases differed in that the reaction mixture contained 0.25mg of yeast RNA, 100,umol of sodium phosphate buffer, pH6.0, 0.5mg of bovine serum albumin and enzyme in 1 ml. After incubation at 25°C for 15min, enzyme activity was determined as above.
Other enzyme assays
Catalase and horse liver alcohol dehydrogenase, which were used as standards in the estimation of the molecular weight of the human spleen RNAase, were assayed as described by Beers & Sizer (1952) and by Vallee & Hoch (1955) respectively.
Enzyme purifications
RNAases from human plasma (Schmukler et al., 1975) , human liver and human spleen (Neuwelt etal., 1976) were purified as described previously. Because all of the purified human RNAases studied have been shown to exist in a variety of aggregated states, it has not been possible to demonstrate the homogeneity of any of the enzymes by polyacrylamide-gel electrophoresis (Neuwelt et al., 1976; Schmukler et al., 1975; .
Protein determinations
Protein concentration was measured by the method of Lowry et al. (1951) , with bovine serum albumin as standard, or at low concentrations (less than 0.05mg/ml) by the fluorescence technique of Bohlen et al. (1973) .
Estimation ofmolecular weight of the enzyme
The molecular weight of the human pancreatic RNAase was estimated by sucrose-density-gradient centrifugation (Martin & Ames, 1961) . It was assumed that the enzyme protein was globular.
Preparation ofantibody to human liver and pancreatic RNAase
The preparation of antibody to human liver RNAase and RNAase A was as described previously (Neuwelt et al., , 1976 . Similarly, antibody to human pancreatic RNAase was prepared as the others, except that human pancreatic RNAase (specific activity 3018 units/g of protein; 8,ug/ml) was suspended in an equal volume of complete Freund's adjuvant and a portion (0.15ml) of the suspension was injected directly into rabbit popliteal lymph nodes . The collection of antiserum was by cardiac procedure.
Detection ofantibody to human ribonucleases
Human liver RNAase, human pancreatic RNAase or RNAase A (2.5 enzyme units in 0.3ml of.0.85% NaCI) was added to a portion (0.1 ml) of pre-and post-immunization rabbit serum. In each case, the mixture was stirred mechanically at 4°C, and after 30min a cold saturated solution of (NH4)2SO4 (0.2ml) was added and stirring was continued for a further 10min (Neuwelt et al., 1976) . After centrifugation (300OOg for 10min) to remove the precipitated enzyme-antibody complexes, RNAase activity in the supernatant solution was measured as described above.
Preparation of immobilized antisera
Unfractionated antiserum (3 ml) obtained as described above was dialysed for 2h against 4 litres of O.1M-NaHCO3 containing 1M-NaCl. The antiserum to human liver RNAase, human pancreatic RNAase or RNAase A was coupled to 12g of CNBr-activated Sepharose 4B essentially as described previously (Neuwelt et al., 1973) , except that the coupling reaction was carried out for 2h at 25°C.
Immunodiffusion studies
Ouchterlony slides were prepared with 1 % agarose, as described previously (Ouchterlony, 1949 of Tris/HCl buffer, pH7.5. After incubation at 25°C for 7.5min, the reaction was stopped by the addition of ml of 20mM-lanthanum nitrate in 2M-HC104 (Schmukler et al., 1972) . Enzyme activity was measured as described in the Experimental section. (Neuwelt et al., 1973) .
Results Purification ofhuman pancreatic RNAase (Table 1) Human pancreas (24.0g) was washed extensively and then homogenized in 120ml of 1.0mM-sodium phosphate buffer, pH 6.8, for 1 min in a Sorvall Omnimixer. Cellular debris was removed by centrifugation at-50000g for 15min and the supernatant solution retained.
The remaining three purification steps (ammonium sulphate fractionation, cellulose phosphate chromatography and affinity chromatography) were carried out in a manner analogous to the methods reported previously for the plasma RNAase (Schmukler et al., 1975) .
Properties ofhuman pancreatic RNAase pH optima. When the production of acid-soluble nucleotides was used as an index of enzyme activity, Vol. 163 considerable variations in pH optima were found, not only between individual substrates, but also between different buffers used in the measurement of hydrolysis ofthesame substrate. Thus, at the optimum pH (7.5) in Tris/HCI buffer, hydrolysis of poly(C) was approx. 1.5 times that at the optimum pH (6.5) in phosphate buffer. The hydrolysis of yeast RNA showed the same optimum pH in either Tris/HCl or phosphate buffer (pH 8.0), but the enzyme activity in phosphate buffer was approximately twice that in Tris/HCl.
Hydrolysis ofsynthetic polyribonucleotides
The activity of the,purified pancreatic enzyme towards synthetic polyribonucleotides paralleled closely that of the plasma RNAase (Schmukler et al., 1975) . Of the homopolymers studied, only poly(C) was significantly attacked. Similarly, only those copolymers containing poly(C) were hydrolysed, except for poly(A,U), which was hydrolysed to a small extent (Table 2) .
Molecular weight. The molecular weight of the purified pancreatic RNAase was estimated by sucrose-density-gradient centrifugation (Martin & Ames, 1961) as 33500 in the presence of 0.05M-sodium phosphate buffer (pH 7.6) and 1.0mM-spermidine at 4°C.
Inhibition by poly(A). Since the inhibitory effects of poly(A) on RNAase from human plasma, liver and spleen and the reversal of that inhibition by spermidine have been investigated (Neuwelt et al., 1976; Schmukler et al., 1975; Heiter et al., 1976) , studies were carried out to determine if similar effects could be demonstrated with human pancreatic RNAase. The results are analogous to those for the other three human enzymes studied in that poly(A) inhibited human pancreatic RNAase activity (Table 3 ) and this inhibition was readily reversed by spermidine. It is noteworthy that compared with human plasma RNAase, the human pancreatic enzyme seemed to be somewhat more sensitive to the effects of spermidine (Table 3) .
Immunodiffusion studies
Initially, immunodiffusion studies were used to examine each post-immunization serum for the presense of antibody against each type of RNAase used Yield 100 76 28 24 Table 3 . Inhibition ofRNAase activity by poly(A) and reversal ofinhibition by spermidine RNAase activity was measured as described in the Experimental section, except that 1 unit of enzyme was used. When the effects of poly(A) were studied, 0.1 5,umol of poly(A) was added to the standard reaction mixture before the addition of substrate [0.1m5,uol of poly(C)]. Reversal of poly(A) inhibition by spermidine was studied in the standard reaction mixture, except that 0.15,umol of poly(A) and 2.O0umol of spermidine were added before the addition of 1 unit of enzyme. The values above are representative of three determinations, and the variation of replicate determinations was less than 7%. and 10Opg/ml (specific activity 775 units/g of protein)
respectively. The antisera were prepared as described in the Experimental section.
as an antigen. Fig. 1 (Neuwelt et al., 1976 ). In contrast with the immunodiffusion studies, this test revealed the presence of a cross-reaction between human pancreatic RNAase and RNAase A, by using anti-(RNAase A) serum (Table 4 Table 4 . Detection ofcross-reactivity ofvarious RNAases by (NH4)2SO4 precipitation ofimmune complexes Individual portions (0.1 ml) of antisera were added to 2.5 units of each of the enzymes listed in the first column of the Table: 0.85% NaCl (0.3 ml) in 0.01 M-Tris/HCl buffer, pH7.5, was then added to each mixture. After incubation for 30min at 4°C, 0.2mnl of a cold saturated solution of (NH4)2SO4 was added and the immunoglobulins were allowed to sediment in the cold for 10min (Neuwelt et al., 1976) . The cloudy mixture was clarified by centrifugation (300OOg for 10min) and enzyme activity in the supernatant solution was determined by the increase in A260 of acid-soluble nucleotides (Kalnitsky et al., 1959) . Control reaction mixtures were prepared as above, except that they contained preimmunization sera in place of antisera. The values shown are averages of six determinations and reflect the percentages of enzyme bound to antisera compared with preimmunization sera. The variation between replicate determinations was less than 5% in all cases.
Enzyme bound to antibody (%) Since the (NH4)2SO4 test cannot differentiate easily between a reaction of identity and a reaction of partial identity between two proteins, an additional procedure was used. The blocking primary enzyme immunoassay utilized previously (Neuwelt et al., 1973) to detect subtle antigenic differences between normal and mutant arylsulphatase A enzymes was adapted to study the human RNAases (Fig. 2) . The assay, although analogous to the blocking solid-phase radioimmunoassays, differs in that the specificity of an enzyme for its substrate is used instead of radioactivity. The theoretical curves that result from the blocking immunoassay are illustrated in Fig. 2(a) , which shows that the maximum enzyme activity in the supernatant solution is obtained by adding the standard enzyme to buffer instead of to the immunoadsorbent. The minimum activity in the supernatant solution is obtained by adding the standard enzyme directly to the immunoadsorbent without the prior addition of any test enzyme. These maximum and minimum values are referred to as the upper and lower baselines. The relationship of the upper plateau values (arrows, Fig. 2a) to the upper and lower baselines directly reflects the ability of the test enzyme to fill the antigen-binding sites on the immunoadsorbent. In a reaction of identity the upper plateau is equal to the upper baseline; in a reaction of partial identity, the upper plateau is anywhere between the two baselines; and, in a reaction of non-identity, there is no upper plateau, simply a straight line equal to the lower baseline.
With this in mind, the blocking immunoassay indicates that the human liver and spleen enzymes are antigenically identical, since the upper plateau for both enzymes is equal to the upper baseline (Fig.  2b) Test enzyme protein (relative concentration) Fig. 2 . Use of the blocking primary enzyme immunoassay (Neuwelt et al., 1973) 
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although very similar antigenically, can be differentiated, since the upper plateau for the plasma RNAase, in contrast withthatforpancreaticRNAase, is slightly below the upper baseline (Fig. 2c) . The curve for the human pancreatic enzyme is shifted to the right of the curve for the plasma RNAase because of a higher concentration of pancreatic-enzyme protein. The blocking immunoassay (Fig. 2c) confirms the results of the (NH4)2S04 test in that it suggests a reaction of non-identity between human liver and pancreas enzymes. That is, when the human liver enzyme is used as the test enzyme, a straight line of activity equal to the lower baseline is obtained. When anti-(RNAase A) serum is used as the immunoadsorbent, the upper plateau for human pancreatic RNAase is consistently just above the lower baseline (Fig. 2d ). This suggests that RNAase A and human pancreas enzyme, although antigenically related, share few antigenic sites. These results, then, are quite consistent with both the immunodiffusion studies ( Fig. 1) and the (NH4)2SO4 test (Table 4) , both of which also indicated a marked antigenic difference between the human and bovine RNAases.
Discussion
Although immunodiffusion techniques are the most commonly used immunoassays in enzymology, these methods are relatively insensitive (Minden & Farr, 1971) and their results can even be misleading (Neuwelt et al., 1973) . The results of the present study further delineate this inadequacy of immunodiffusion as a sole means of detecting the presence of antibody and/or of distinguishing antigenic differences between two enzyme proteins. Thus the immunodiffusion studies reported here did not detect the presence of any antibody in three rabbits immunized with purified liver RNAase, in contrast with the positive results obtained with the blocking immunoassay and the (NH4)2S04 test. In addition, the immunodiffusion slides did not reveal any cross-reaction between the human and bovine pancreatic enzymes, which was detected when the two primary binding tests were used. In short, primary binding tests were considerably more sensitive and specific than immunodiffusion methods in the immunological evaluation of human and bovine RNAases. The results of the primary binding tests using antisera against human RNAases revealed several clear differences between the enzymes studied. The four human RNAases fell into two non-crossreacting groups immunologically; the pancreas and plasma enzymes were in one group and the liver and spleen enzymes in the other. Thus the pancreas and plasma RNAases can be unambiguously differentiated from the liver and spleen RNAases on an immunological basis. Antigenic differences were not found between the liver and spleen enzymes, in agreement with reports describing the properties of the two proteins (Neuwelt et al., 1976; . In contrast, immunological studies of the human and bovine pancreatic RNAases revealed a very large antigenic difference between the two enzymes, a finding which, of course, is not surprising in view of their very different enzymic properties (Schmukler et al., 1975; Fruchter & Crestfield, 1965) . The human plasma and pancreatic RNAases appear to be quite closely related, in spite of a small, but consistent, antigenic difference. A further difference should also be noted, i.e. the increased sensitivity of the human pancreatic enzyme to spermidine. The significance of these immunological and enzymic differences is unclear at this time, since by other criteria the human plasma and pancreatic proteins appear to be quite similar (Schmukler et al., 1975) . Clinical studies also suggest that the two enzymes may be related, since pathological processes involving the pancreas result either in an increase (Reddi & Holland, 1976) or in a decrease (Bardon et al., 1976) in plasma RNAase activity. Thus, although the antigenic and enzymic differences described here are 0.1% bovine serum albumin in 0.85% NaCI. After the mixture was incubated at 4°C for 30min, the standard enzyme, human liver RNAase (5 units), was added to the reaction mixture. After another 30min incubation, the conjugated Sepharose was allowed to settle and a portion of the supernatant solution was assayed for RNAase activity. The upper and lower horizontal lines represent the upper and lower baselines as discussed in Fig. 2(a) (Bardon et al., 1976; Reddi & Holland, 1976) .
